India to get 97 million doses of Serum-made AstraZeneca vaccine from Covax

As of now, Covax has not disclosed the India distribution plan for the Pfizer-BioNTech vaccine

According to the interim distribution forecast released by Covax, the World Health Organization (WHO)-Gavi initiative to ensure equitable distribution of vaccine across the globe, India will get around 97 million doses of the AstraZeneca vaccine made by Serum Institute of India (SII). As of now, Covax has not allotted the Pfizer-BioNTech vaccine for India. 

The document highlights that India is in line to receive around 97,164,000 doses of AstraZeneca vaccine licensed to SII in the first and second quarters of 2021. The Covax plan states how the 240 mn doses of the AstraZeneca-Oxford vaccine would be distributed across countries as